Emcure Pharma IPO Details, Date, Allotment

Emcure Pharma IPO: Emcure Pharmaceuticals Limited IPO is a book-built issue, which includes a fresh issue worth Rs 800 crore and an offer for sale of 1.14 crore shares.

The Emcure Pharma IPO will be open for subscription from July 3, 2024, to July 5, 2024. The allotment of shares is expected to be finalized on July 8, 2024. Emcure Pharma’s shares are planned to be listed on the BSE and NSE, with the tentative listing date set for July 10, 2024.

Source from Emcure Pharma IPO RHP

 Emcure Pharma IPO Details, Date, Allotment

Emcure Pharma IPO Details

Open DateJuly 3, 2024
Close DateJuly 5, 2024
IPO SizeAggregating up to ₹. Cr.
Fresh Issuea fresh issue worth Rs 800 crore
Face Value₹10 per share
IPO Price Band₹960 to ₹1008 per share
IPO Listing onNSE SME
Lot Size14 Shares
OFS1.14 crore shares
Share Offered to Retail35%
Share Offered to QBI50%
Share Offered to HNI15%

Emcure Pharma IPO Date

  • Emcure Pharma IPO Open Date: July 3, 2024
  • IPO Close Date: July 5, 2024
  • Emcure Pharma IPO allotment: July 8, 2024
  • Refunds: July 9, 2024
  • Shares Credit to Demat: July 9, 2024
  • Emcure Pharma IPO Listing Date: July 10, 2024

Lot Size

Here is the table based on the provided information:

ApplicationLots RangeShares RangeAmount Range (₹)
Retail1 – 1414 – 196₹14,112 – ₹197,568
S-HNI15 – 70210 – 980₹211,680 – ₹987,840
B-HNI (Min)71 –994 –₹1,001,952 –

Please note:

  • “B-HNI (Min)” continues from Lot 71 onwards.
  • Shares and Amount ranges are provided based on the minimum and maximum values given.
  • The Amount range for “B-HNI (Min)” is not fully specified due to the lack of specific maximum Lot and Share values provided in the original data.

Emcure Pharma IPO GMP (Grey Market Premium)

If you want to know Emcure Pharma IPO GMP (Grey Market Premium) then please visit our IPO GMP section and get daily updates on grey market premium. We update here all IPOs GMP.

Emcure Pharma IPO Subscription Status

Emcure Pharma IPO subscription starts on July 3, 2024, To get live IPO subscription status data go to our IPO Subscription section and see any ongoing IPO Subscription Status.

Emcure Pharma IPO Allotment Status

To check Emcure Pharma’s IPO allotment status go to the IPO registrar website ”Link Intime India Private Limited” or go to IPO Allotment>>.
You can find here any IPO allotment status. Following some stapes.

  1. Go to the Link given above.
  2. Select the IPO Name
  3. Enter your PAN/ DP ID/ Application No
  4. Submit details and get the allotment status.

Know About Company

Emcure Pharmaceuticals Limited was founded in 1981, Emcure Pharmaceuticals Limited is an Indian company that develops, manufactures, and sells a wide range of pharmaceutical products globally.

Ranked 13th in domestic sales among Indian pharmaceutical companies for the MAT (Moving Annual Total) ending September 2023, Emcure holds a significant position in the market. It also ranks 4th in market share in its covered markets during the same period. Notably, Emcure leads in the gynaecology and HIV antiviral therapeutic areas for the MAT ending September 2023.

For the six months ending September 30, 2023, and the Financial Year 2023, sales in India made up 50.84% and 53.16% of Emcure’s total revenue, respectively. The company’s domestic sales grew at a compound annual growth rate (CAGR) of 10.80% from September 2019 to September 2023, outperforming the overall Indian pharmaceutical market.

As of September 30, 2023, Emcure employed 552 scientists and operated five research facilities in India. The company filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. Emcure has 201 granted patents, 33 pending patent applications, and has submitted 102 drug master files.

Emcure Pharmaceuticals operates 13 manufacturing facilities across India. These facilities produce a variety of pharmaceutical and biopharmaceutical products, including tablets, liquids, injectables, and complex ingredients like chiral molecules, iron molecules, and cytotoxic substances.

Objects of the Issue

  1. Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the Company; and
  2. General corporate purposes.

Promoters Holding

Satish Mehta and Sunil Mehta are the promoters of the company. Pre-issue shareholding: 98.90%

Emcure Pharmaceuticals Limited Financial Report

Period Ended31 Mar 202431 Mar 202331 Mar 2022
Assets₹7,806.16 Cr₹6,672.53 Cr₹6,063.47 Cr
Revenue₹6,715.24 Cr₹6,031.72 Cr₹5,918.86 Cr
Profit After Tax₹527.58 Cr₹561.85 Cr₹702.56 Cr
Net Worth₹2,952.28 Cr₹2,501.13 Cr₹1,987.55 Cr
Reserves and Surplus₹2,722.40 Cr₹2,293.77 Cr₹1,791.03 Cr
Total Borrowing₹2,091.94 Cr₹2,202.42 Cr₹2,102.19 Cr

Between the financial years ending March 31, 2023, and March 31, 2024, Emcure Pharmaceuticals Limited saw a revenue increase of 11.33%, while the profit after tax (PAT) decreased by 6.1%.

KPI Of Emcure Pharmaceuticals Limited

Particulars202420232022
EBITDA (₹ Crore)₹1,276.78₹1,220.94₹1,393.38
EBITDA Margin (%)19.01%20.24%23.54%
PAT (₹ Crore)₹527.58₹561.85₹702.56
PAT Margin (%)7.86%9.31%11.81%
RoCE (%)19.37%22.01%29.69%

In the financial year ending March 31, 2024, Emcure Pharmaceuticals Limited’s revenue from Indian operations accounted for 48.28%, while international sales contributed 51.72%. The EBITDA for the year was ₹1,276.78 crore, with an EBITDA margin of 19.01%. The PAT for the year was ₹527.58 crore, resulting in a PAT margin of 7.86%. The return on capital employed (RoCE) was 19.37%.

Peer Group

  • Dr. Reddy’s Laboratories Limited
  • Cipla Limited
  • Alkem Laboratories Limited
  • Torrent Pharmaceuticals Limited
  • Mankind Pharma Limited
  • Abbott India Limited (Standalone)
  • J. B. Chemicals & Pharmaceuticals Limited

Emcure Pharmaceuticals Limited IPO Registrar

Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: + 91 810 811 4949
E-mail: emcure.ipo@linkintime.co.in
Website: www.linkintime.co.in

Emcure Pharmaceuticals Limited IPO Lead Manager

  • Kotak Mahindra Capital Company Limited
  • Axis Capital Limited
  • Jefferies India Private Limited
  • J. P. Morgan India Private Limited

Emcure Pharmaceuticals Limited Contact

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: investors@emcure.co.in
Website: https://www.emcure.com/

Emcure Pharmaceuticals Limited IPO Application Form PDF

To download the Emcure Pharmaceuticals Limited IPO application form Check out the Application Form Download ASBA IPO Forms PDF.

FAQs

What is the IPO size of Emcure Pharmaceuticals Limited?

Emcure Pharmaceuticals’ IPO comprises a fresh issue of ₹800 crore and an offer for sale of 1.14 crore shares.

When will Emcure Pharmaceuticals Limited IPO open for subscription?

The Emcure Pharma IPO will open for subscription on July 3, 2024.

When is the allotment of Emcure Pharmaceuticals IPO shares expected?

Allotment of Emcure Pharmaceuticals IPO shares is scheduled to be finalized on July 8, 2024.

When will Emcure Pharmaceuticals IPO shares be listed on the stock exchanges?

Emcure Pharmaceuticals’ shares are expected to be listed on BSE and NSE on July 10, 2024.

Rate this post

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest Post

Advertisement

Zerodha Ads
Fyers
Scroll to Top